Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.90
3.05 (0.33%)
< Home < Back

Natco Pharma informs about disclosure

Date: 03-10-2025
Natco Pharma has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanjay Nannapaneni.

The above information is a part of company’s filings submitted to BSE.